Description of Business (Details Narrative) - USD ($)	1 Months Ended		12 Months Ended
	Jun. 30, 2015	Jul. 31, 2014	Dec. 31, 2015	Dec. 31, 2007
Principal amount, note offering				$ 200,000
Shares issued	286,500		272,000
Payment for business combination			$ 50,000
Note Financing [Member]
Principal amount, note offering		$ 500,000	$ 121,500
Shares issued		200,000	243,000
Shares issued, value		$ 200,000
Note interest rate		10.00%
Maturity date		Dec. 31, 2015	Dec. 31, 2015
Note Financing [Member] | Commitments to Extend Credit [Member]
Shares issued			286,500
Global Cancer [Member]
Share value			$ .01
Business combination agreement date			Sep. 03, 2015
Ownership percent			100.00%
Payment for business combination			$ 50,000
Business combination contingent payment terms			In the event the Company and Global execute definitive merger documents contemplated by the Global LOI on or before the Termination Date, Global will issue to the Company that number of shares of Global’s common stock equal to 10% of the then outstanding shares of Global’s common stock, on a fully-diluted basis as payment of the Global Advance.